Features of vaginal microbiota in women with vulvovaginal candidiasis
, 1, 1, 1
Abstract
Introduction: Dysbiotic changes in the microbiota of the genital tract in candidal vulvovaginitis are manifested
by the formation of associations of Candida fungi with various representatives of opportunistic microflora
against the background of Lactobacillus spp. deficiency. In the vast majority of cases, the causative agent
of the infection is Candida albicans, with Candida non-albicans being less frequently registered.
Material and methods: To assess the species and quantitative composition of the vaginal microflora in
women, bacteriological studies were conducted. The research group consisted of 60 women with candidal
vulvovaginitis. The control group consisted of 30 healthy women.
Results: The results indicate that in 95% of women with vulvovaginal candidiasis, the vaginal microbiota is
characterized by the formation of 2–4 component associations of Candida fungi with various representatives
of facultatively anaerobic and obligately anaerobic conditionally pathogenic microflora. The species
spectrum of fungi isolated from the genital tract of women with candidal vulvovaginitis mainly included
C. albicans (75%) and, less frequently, Candida non-albicans (25%). In healthy women, C. albicans was
recorded in 10% of those examined, and Candida non-albicans in 6.6%.
Conclusions: An increase in the frequency of detection of Candida non-albicans species in the spectrum
of fungi isolated from the vagina of women with candidal vulvovaginitis, an increase in the frequency of
fungal-bacterial associations of microorganisms, as well as a deficiency or absence of Lactobacillus spp.,
confirms the importance of constant bacteriological monitoring to identify changes in the composition of
the vaginal microbiota and prescribe adequate therapy.
Keywords: vulvovaginal candidiasisvaginal microbiotaCandidaconditionally pathogenic microorganisms
References
- Nyirjesy P, Brookhart C, Lazenby G, et al. Vulvovaginal Candidiasis: A Review of the Evidence for the 2021 Centers for Disease Control and Prevention of Sexually Transmitted Infections Treatment Guidelines. Clin Infect Dis. 2022; 74(Suppl_2): S162–S168.
- Yano J, Sobel JD, Nyirjesy P, et al. Current patient perspectives of vulvovaginal candidiasis: incidence, symptoms, management and post-treatment outcomes. BMC Womens Health. 2019; 19(1): 48.
- Rosati D, Bruno M, Jaeger M, et al. Recurrent Vulvovaginal Candidiasis: An Immunological Perspective. Microorganisms. 2020; 8(2).
- Cooke G, Watson C, Smith J, et al. Treatment for recurrent vulvovaginal candidiasis (thrush). Cochrane Database of Systematic Reviews. 2011.
- Farhan MA, Moharram AM, Salah T, et al. Types of yeasts that cause vulvovaginal candidiasis in chronic users of corticosteroids. Med Mycol. 2019; 57(6): 681–687.
- Gaziano R, Sabbatini S, Monari C. The Interplay between Vaginal Mucosa, Host Immunity and Resident Microbiota in Health and Disease: An Overview and Future Perspectives. Microorganisms. 2023; 11(5).
- Chen X, Lu Y, Chen T, et al. The Female Vaginal Microbiome in Health and Bacterial Vaginosis. Front Cell Infect Microbiol. 2021; 11: 631972.
- Willems HME, Ahmed SS, Liu J, et al. Vulvovaginal Candidiasis: A Current Understanding and Burning Questions. J Fungi (Basel). 2020; 6(1).
- Donders GGG, Ravel J, Vitali B, et al. Role of Molecular Biology in Diagnosis and Characterization of Vulvo-Vaginitis in Clinical Practice. Gynecol Obstet Invest. 2017; 82(6): 607–616.
- Aguirre-Quiñonero A, Castillo-Sedano IS, Calvo-Muro F, et al. Accuracy of the BD MAX™ vaginal panel in the diagnosis of infectious vaginitis. Eur J Clin Microbiol Infect Dis. 2019; 38(5): 877–882.
- Rodríguez-Cerdeira C, Gregorio MC, Molares-Vila A, et al. Biofilms and vulvovaginal candidiasis. Colloids Surf B Biointerfaces. 2019; 174: 110–125.
- Bertolini M, Ranjan A, Thompson A, et al. Candida albicans induces mucosal bacterial dysbiosis that promotes invasive infection. PLoS Pathog. 2019; 15(4): e1007717.
- d'Enfert C, Kaune AK, Alaban LR, et al. The impact of the Fungus-Host-Microbiota interplay upon Candida albicans infections: current knowledge and new perspectives. FEMS Microbiol Rev. 2021; 45(3).
- Galocha M, Pais P, Cavalheiro M, et al. Divergent Approaches to Virulence in and : Two Sides of the Same Coin. Int J Mol Sci. 2019; 20(9).
- Malinovská Z, Čonková E, Váczi P. Biofilm Formation in Medically Important Species. J Fungi (Basel). 2023; 9(10).
- Swidsinski A, Guschin A, Tang Q, et al. Vulvovaginal candidiasis: histologic lesions are primarily polymicrobial and invasive and do not contain biofilms. Am J Obstet Gynecol. 2019; 220(1): 91.e1–91.e8.
- Maza PK, Bonfim-Melo A, Padovan ACB, et al. : The Ability to Invade Epithelial Cells and Survive under Oxidative Stress Is Unlinked to Hyphal Length. Front Microbiol. 2017; 8: 1235.
- Chen Z, Jin J, Chen H, et al. The bacterial communities in vagina of different Candida species-associated vulvovaginal candidiasis. Microb Pathog. 2023; 177: 106037.
- Tortelli BA, Lewis WG, Allsworth JE, et al. Associations between the vaginal microbiome and Candida colonization in women of reproductive age. Am J Obstet Gynecol. 2020; 222(5): 471.e1–471.e9.
- Zheng N, Guo R, Wang J, et al. Contribution of to Vaginal Health and Diseases: A Systematic Review. Front Cell Infect Microbiol. 2021; 11: 792787.
- Ouarabi L, Drider D, Taminiau B, et al. Vaginal Microbiota: Age Dynamic and Ethnic Particularities of Algerian Women. Microb Ecol. 2021; 82(4): 1020–1029.
- Saraf VS, Sheikh SA, Ahmad A, et al. Vaginal microbiome: normalcy vs dysbiosis. Arch Microbiol. 2021; 203(7): 3793–3802.
- Seyoum E, Bitew A, Mihret A. Distribution of Candida albicans and non-albicans Candida species isolated in different clinical samples and their in vitro antifungal suscetibity profile in Ethiopia. BMC Infect Dis. 2020; 20(1): 231.
- Zuo XS, Liu Y, Cai X, et al. Association of different Candida species with catheter-related candidemia, and the potential antifungal treatments against their adhesion properties and biofilm-forming capabilities. J Clin Lab Anal. 2021; 35(4): e23738.
- Surain P, Aggarwal N. Candida, a human pathogen and major types of candidiasis . Int J Pharm Sci & Res. 2019; 11(1): 41–67.
- Sun Z, Ge X, Qiu Bo, et al. Vulvovaginal candidiasis and vaginal microflora interaction: Microflora changes and probiotic therapy. Front Cell Infect Microbiol. 2023; 13: 1123026.
- Ceccarani C, Foschi C, Parolin C, et al. Diversity of vaginal microbiome and metabolome during genital infections. Sci Rep. 2019; 9(1): 14095.
- Kunselman AR. A brief overview of pilot studies and their sample size justification. Fertil Steril. 2024; 121(6): 899–901.
- Rabi S, Solafa A, Reem A. Prevalence of vulvovaginal Candidiasis and its association with Contraceptives. Archivos Venezolanos de Farmacología y Terapéutica. 2021; 20(4): 373–376.
- Mesquida A, Machado M, Dávila-Cherres L, et al. The Gastrointestinal Tract Is Pinpointed as a Reservoir of , , and Genotypes Found in Blood and Intra-Abdominal Samples. J Fungi (Basel). 2023; 9(7).